Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CAP1 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA589912
Description
Immunogen sequence: MADMQNLVER LERAVGRLEA VSHTSDMHRG YADSPSKAGA APYVQAFDSL LAGPVAEYLK ISKEIGGDVQ KHAEMVHTGL KLERALLVTA SQCQQPAENK; Positive Samples: HeLa, 293T, A-431, HepG2, Rat thymus, Mouse thymus; Cellular Location: Cell membrane, Peripheral membrane protein.
Adenylyl cyclase-associated protein 1 is an enzyme that in humans is encoded by the CAP1 gene. This gene is mapped to 1p34. 2. The protein encoded by this gene is related to the S. cerevisiae CAP protein, which is involved in the cyclic AMP pathway. And the human protein is able to interact with other molecules of the same protein, as well as with CAP2 and actin. Alternatively spliced transcript variants have been identified.
Specifications
CAP1 | |
Polyclonal | |
Unconjugated | |
CAP1 | |
adenylate cyclase associated protein 1; adenylyl cyclase-associated CAP protein, yeast homolog 1; adenylyl cyclase-associated protein 1; CAP; CAP 1; CAP, adenylate cyclase-associated protein 1; CAP, adenylate cyclase-associated protein 1 (yeast); CAP1; CAP1-PEN; cyclase-associated protein homologue; Mch1; RP11-115D7.1; testis secretory sperm-binding protein Li 218p | |
Rabbit | |
Affinity Chromatography | |
RUO | |
10487, 12331, 64185 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
ELISA, Western Blot | |
0.44 mg/mL | |
PBS with 50% glycerol and 0.01% thimerosal; pH 7.3 | |
P40124, Q01518, Q08163 | |
CAP1 | |
A synthetic peptide corresponding to a sequence within amino acids 1-100 of human CAP1 (NP_0063581). | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction